Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Arbutus Biopharma Corp (ABUS)

171 + Investors. Track Smart Money conviction in ABUS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +9
Streak
1Q ▲
Buyers last Q
60%

Smart Money Signals — ABUS

Based on 174 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ABUS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (99% of max)

99% of all-time peak
174 hedge funds hold ABUS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +6% more funds vs a year ago

fund count last 6Q
+10 new funds entered over the past year (+6% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟢

More buyers than sellers — 60% buying

101 buying67 selling
Last quarter: 101 funds were net buyers (36 opened a brand new position + 65 added to an existing one). Only 67 were sellers (40 trimmed + 27 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+8 vs last Q)

new funds entering per quarter
Funds opening a new ABUS position: 24 → 23 → 28 → 36. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

54% of holders stayed for 2+ years

■ 54% conviction (2yr+) ■ 28% medium ■ 18% new
94 out of 174 hedge funds have held ABUS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +37% but shares only +1% — price-driven

Value
+36%
Shares
+1%
Last quarter: the total dollar value of institutional holdings rose +37%, but actual share count only changed +1%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

15 → 24 → 23 → 28 → 36 new funds/Q
New funds entering each quarter: 24 → 23 → 28 → 36. A growing number of institutions are discovering ABUS each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 58% veterans vs 21% newcomers

■ 58% veterans ■ 21% 1-2yr ■ 21% new
Entry-cohort mix of 177 holders: 103 (58%) are 2+ year veterans, 37 entered 1–2 years ago, and 37 (21%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 58% AUM from top-100 funds

58% from top-100 AUM funds
44 of 173 holders are among the 100 largest funds by AUM, controlling 58% of total institutional value in ABUS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ABUS

In 2026 Q2, 101 hedge funds were net buyers of ABUS (36 opened a new position, 65 added to an existing one), while 67 reduced or exited (40 trimmed, 27 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. 58% of total institutional value in ABUS is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +9 funds (more new holders than closures). Total institutional holders: 174.

Hedge Fund Ownership: ABUS

How many hedge funds hold ABUS — quarterly history vs. share price
Quarterly hedge fund ownership of ABUS vs. share price

Market Analysis: ABUS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ABUS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

8 top-rated funds 2 high-conviction
Consensus
4.1
/ 10
breadth
×
Elite
3.1
/ 10
conviction
Hedge Fund Positioning: ABUS
171 + Investors

Track Smart Money conviction in ABUS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 171 165 3.64%
13F Shares 141M 140M 0.6%
Total Value $673M $628M 7.12%
New Positions 35 28 +7
Increased Positions 61 46 +15
Closed Positions 28 37 -9
Reduced Positions 40 50 -10
Total Calls 2 5 -60.0%
Total Puts 2 4 -50.0%
PUT/CALL Ratio 1.0 0.8 Neutral

Statistics: ABUS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

171 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ABUS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ABUS holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Whitefort Capital Management, LP 18.69% 15,794,261 $75.8M
2 Rangeley Capital, LLC 2.19% 500,000 $2.4M
3 Two Seas Capital LP 1.82% 19,095,583 $91.7M
4 BlackBarn Capital Partners LP 1.01% 2,500,000 $12.0M
5 Western Standard LLC 0.88% 542,787 $2.6M
6 Deltroit Asset Management (UK) LLP 0.83% 1,200,000 $5.8M
7 Ledgewood Wealth Advisors, LLC 0.71% 278,436 $1.3M
8 Rubric Capital Management LP 0.33% 7,532,937 $36.2M
9 ADAR1 Capital Management, LLC 0.28% 1,268,147 $6.1M
10 Wealth Management Associates, Inc. 0.20% 147,995 $710K
11 Carrera Capital Advisors 0.18% 257,167 $1.2M
12 Front Row Advisors LLC 0.15% 110,500 $516K
13 Exome Asset Management LLC 0.15% 50,166 $241K
14 CenterBook Partners LP 0.10% 445,151 $2.1M
15 Virtus Investment Advisers, LLC 0.09% 76,807 $369K
16 Integrated Quantitative Investments LLC 0.06% 79,937 $384K
17 Campbell & CO Investment Adviser LLC 0.06% 230,534 $1.1M
18 Quinn Opportunity Partners LLC 0.06% 255,214 $1.2M
19 Freestone Capital Holdings, LLC 0.06% 442,500 $2.1M
20 Jefferies Financial Group Inc. 0.05% 1,711,672 $8.2M
21 JBF Capital, Inc. 0.05% 80,281 $385K
22 Woodline Partners LP 0.03% 2,281,856 $11.0M
23 Kennedy Capital Management LLC 0.03% 385,298 $1.8M
24 Cura Wealth Advisors, LLC 0.03% 15,000 $72K
25 WMG Financial Advisors, LLC 0.02% 12,605 $61K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Arbutus Biopharma Corp (ABUS)

What does the Smart Money Trend signal show for ABUS?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ABUS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ABUS?

More buyers than sellers — 60% buying: Last quarter: 101 funds were net buyers (36 opened a brand new position + 65 added to an existing one). Only 67 were sellers (40 trimmed + 27 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ABUS holders?

Elite ownership — 58% AUM from top-100 funds: 44 of 173 holders are among the 100 largest funds by AUM, controlling 58% of total institutional value in ABUS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ABUS?

54% of holders stayed for 2+ years: 94 out of 174 hedge funds have held ABUS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →